COPD Pulmonary emphysema

use of somatovital therapy at COPD

The COPD is a pulmonary disease on the rise. Through somatovital therapy (spirovitalization), COPD sufferers can alleviate their symptoms and new or more quality of life through this therapy (see experience reports /specialist literature).

What is COPD

COPD (Chronic obstructive pulmonary disease) is a collective drawing for chronic diseases of the airways. The main feature is the production of viscous, purulent mucus in the lungs, which is difficult to cough. Emphysema often also form.

This leads to shortness of breath and makes the simplest everyday jobs difficult for those affected. Probable cause of the COPD is a long overload of the lungs z. B. by smoking or a fine dust -loaded job. How far the disease has progressed can be determined by the lung function test. With the FEV1 value, this indicates how much air can be exhaled in a second. The results are divided into the so-called gold stadiums. With gold i, the symptoms are still little pronounced, but gold IV, on the other hand, often means that the quality of life is extremely limited.

New COPD knowledge

The resulting lung damage is generally considered irreversible. Only individual symptoms can be reduced. Studies have impressively demonstrated that spirovital therapy can achieve exceptionally good results, especially in the case of lung diseases. In contrast to classic oxygen therapy, spirovitalization is not added a higher amount but more high -quality oxygen. So the lung can better use the oxygen with the same performance. The results are often fewer colds, easier coughing on the mucus and thus freer breathing. A higher well -being and more physical energy are the result. Many users even report that the go and climbing stairs is easier for them again. All body cells rely on the constant supply of oxygen. The oxygen content of the inhalation air, the functionality of the respiratory tract, the diffusion capacity for oxygen from the alveoli into the vascular system, the transport via an intact vascular system and sufficient and functional erythrocytes, an orderly transition of oxygen from the capillaries into the tissue, a permeable interstitium, an intact in the individual cells, Further transport in numerical and functional mitochondria as well as optimal enzyme capacity for aerobic metabolism. Disruptions are conceivable in many places. In the case of pulmonary emphysema, the problem is primarily due to the inadequate diffusion capacity for oxygen from the alveoli into the vascular system. In chronic bronchitis, the inflammation and narrowing is added to the laying of bronchioles or bronchi. The full screen of the COPD is characterized by the additional formation and the "non-or heavy coughing" of tough mucus and increasing shortness of breath (oxygen shortage). There is therefore no lack of oxygen from the breathing air, but the oxygen does not reach the destination (mitochondria). Spirovitalization reduces this deficit or at least partially raises the problem.

Airnergy-the breathing air supplement with the forest bath effect

helps to improve the quality of life and self -healing at COPD & Co. and ...
Next: (fold down)

By short-term activation of the inhalation air before entering the airways, the molecular oxygen of the ambient air, which is sluggish, is activated (by the formation of singlet oxygen, a stimulated but not radicalized form). This active condition only lasts fractions of seconds. Before the air is inhaled, the activated oxygen falls back into the original (reason) condition. The energy previously absorbed is freely released and the surrounding water is released through which the breathing air is led. With the inhalation of the atmospheric oxygen, the respiratory tract is also added to the aircraft saturation of the inhalation air, which initiates the desired increase in oxygen recycling. This water -mediated energy transmission, on the one hand, in the erythrocytes there is an increase in 2.3diphosphoglycerate (2.3dPG), an important vitalizer of the intermediate molecular phosphate group compensation when converting 3PG into 2PG, an important step of the anaerobal acacitous energy generation in the erythocytes. In general, the concentration of the 2.3dPG is low, and spirovitalization demonstrably increases it significantly. This means that 3PG can be transferred to 2PG faster, which again accelerates the transition of 1.3dPG to 3PG with increased formation of ATP at the same time, with the result that the oxygen binding curve shifted to the right. This increases the PO2 with the same o2 saturation or remains the same when the PO2 is lower. This means an increased oxygen levy to the environment, synonymous with a possible improvement in the utilization of oxygen, which is also manifested in an increase in AVDO2.

This mechanism explains the observation that, despite the less diffusion of oxygen from the alveoli, spirovitalization can contribute to an adequate supply of oxygen for the individual organ systems. A second important impact of spirovitalization is the increase in immune competence. On the one hand, this is caused by an increased activity of the white blood count, reduced willingness to inflammation and a decrease in oxidative stress. Furthermore, spirovitalization (singer oxygen) demonstrably leads to the intercept of reactive types of oxygen (ROS) or to reduce O2 -radical formation. Irreversible damage to amino acids in the human body, caused by atmospheric nitrate radradicals, are assessed by experts as a potential cause of the occurrence of respiratory diseases.

In 2007, the scientific evaluation of declining statements by spiro users and spirovital therapists in recent years, an overall revealing analysis. In 42 protocols there was 163 diseases or disorders (3.9 information per protocol). 77 percent of the complaints communicated extended to functional, 23 percent to organic areas. There was no age dependency on success, the information was sufficient from 21 to 91 years. Sometimes there was a temporary deterioration, at the latest from the 7th day of application there were significant subjective, usually also objective improvements.

COPD End user: Inside ❤ With Airnergy

An evaluation of the end users Information on the Effectiveness of Spirovitalization In organic diseases, showed that the device was used successfully even in the event of respiratory diseases, in detail at asthma bronchial, sleep apnea, bronchitis, COPD and pulmonary emphysema. With regard to the functional disorders that are common in COPD, the end users showed a positive assessment of spirovital therapy for energy status (performance, activity, resilience, strength, motivation), the well -being (quality of sleep, mood, breathing, digestion, pain, immune system) and regeneration (deepening, acceleration, relaxation, pulse recovery). The individual aspects met for all end users, but the ranking vary, depending on the individual starting point. There is therefore no doubt that many of the specified positive functional changes also affect the clinical picture "COPD with pulmonary emphysema".

therapist for COPD, etc. With Airnergy

The therapist assessment also showed an effective use of spirovital therapy for diseases of the respiratory tract. Asthma and COPD were cited as special indications. In the opinion of the therapists, the functional disorders associated with COPD and asthma can also be influenced well through spirovitalization, in particular the drop in performance, sleep disorders and weakening of the immune system. Dr. Klaus Jung / Dr. phil. Dinah Jung (2014) Handbook on somatovital therapy Part II: Studies and practical experience - Monsenstein and Vannerdat

COPD with Airnergy ❤ Experience Practice ticker

• COPD with pulmonary emphysema, PAO2 approx. 50 mmHg, permanent O2 therapy so far due to relatively good subjective condition, partial improvement after acupuncture, skeptical attitude towards spiro, start with 3 x 10 or later 3 x 15 min daily, 3 x/ wo. Overall positive judgment.
• Clinic diagnosis: infect-aerobic COPD with pulmonary emphysema, reinforced formation of tough hard-to-tough mucus, nocturnal coughing fits, after spirovitization (daily 1 x 21 min) Lighter coughing on a lot and more fluid mucus, outer breathing.
• COPD with pulmonary emphysema, 71 a, severe deterioration in recent years, most recently increasing shortness of breath, specialist medical treatment, after cold (wet cold weather) strong setback, after spirovitalization immediate improvement (no longer shortness of breath, walking and climbing stairs again).
• COPD since approx. 12 A, side effects due to drug therapy (stomach, eyes), even after the first spirovital application, clear subjective and objective improvement (well -being, activity, fewer medication, above all, predisone reduction, no more cold, no more cold increase in oxygen saturation).
• COPD as a result of smoking and professional asbestos pollution, 55 a, shortness of breath, energy deficiency 25 m, no longer able to get significant improvement (more air, more energy), increase of the PAO2 from less than 90 mmHg, improvement of the lung function, even 1 A later, no relapse, overall significant improvement (in the working process, on the home trainer physical and psychological performance).
• COPD, 66 a, since 5 A in specialist treatment, since spirovititalization no more colds, more energy, better subjective condition, increasing the oxygen content in the blood, less cough, easier walking.
• COPD, 59 a, after Spirovitization short -term deterioration of subjective well -being, then "amazing" improvement (climbing stairs without shortness of air, raising the energy level, better sleep, no longer fatigue).
• COPD, 78 A, strong smoker throughout life, before 4 A after pneumonia Severe deterioration in the subjective and objective state (COPD), inhaler regulation, further deterioration to total immobility, after Spirovitalization Continuous increase in the FEV1 from 0.80 l and the FVC from 1.86 l to more than 3.10 l (increase by 210 or 1,150 ml). A significant increase in subjective well -being and performance.
• COPD, 65 a, constant mucus, additionally osteoporosis, rheumatoid arthritis, osteoarthritis; Maximum walking distance approx. 200 m, shortness of air, no appetite; Since the spiro use Reduction of the inhal applications, increase in the peak flow (PEF) from 200 to 300 l/ min, regular participation in lung sport without problems, more energy, more endurance, no more shortness of breath, improvement in blood circulation, easier coughing on more fluid mucus, improvement of sleep, more self -confidence, better.

❤ Read some other authentic experiences of the users with COPD from Airnergy atmospheres, you are welcome to request more directly from us.

---

COPD Gold IV

COPD - InfoIn the final stage COPD Gold IV - the very heavy COPD - the disease is already well advanced.
The lung function differs by more than 70% from the normal value and the lung bubbles are almost only bloated, which is then referred to as emphysema. But also at COPD Gold IV, spirovital therapy can still be used to improve the lung function, as a placebo -controlled study shows. This means that the lung cells and other organs and systems can improve their function. However, from a holistic, biological and physiological point of view, certain conditions must be created in the body. The COPD GOLD IV suffered from severe shortness of breath also suffer from the state of rest, which is why the physical performance and their quality of life are severely restricted.

Knowing that the lung function in those affected can improve according to COPD Gold IV is not available in the minds of most lung pollutants. Unfortunately, a lot is believed, accepted and dogmatized here, as with some religious communities. New successful, holistic therapy methods are categorically ignored and rejected without having checked them. Spirovital therapy has a significant improvement in the lung function in COPD Gold IV, especially the value FEV1%. Inhaling 2 times a day, for 20 minutes, for over 6 months and the results also show a significant improvement in the lung function at COPD Gold IV, whereby the placebo control group could not show any effects, not even the so -called placebo effect.

As a crowning glory for the pessimists, skeptics and doubters, spirovital therapy even provides scientific evidence that is significantly higher than medical evidence. In plants that are known to be unable to imagine (placebo effect), it was demonstrated at an institute of the Humboldt University in Berlin that root growth in plants has been significantly improved.

Have you ever heard of a scientific evidence of medication, medication that works in both humans, animals and plants without side effects? This means that spirovital therapy copies and uses a technology that is deeply anchored in nature and has a variety of positive effects on humans, animals and plants, also affected by COPD Gold IV.


The COPD compendium Also read: Strengthening at COPD / another PDF